Y-mAbs Therapeutics, Inc.
USE OF ANTI-B7H3 ANTIBODIES FOR TREATING CANCER IN THE CENTRAL NERVOUS SYSTEM
Last updated:
Abstract:
The presently disclosed subject matter provides uses of anti-B7H3 antibodies for treating cancers in the central nervous system (CNS), including tumors metastatic to CNS, and in particular leptomeningeal carcinomatosis.
Status:
Application
Type:
Utility
Filling date:
14 May 2018
Issue date:
25 Jun 2020